Researchers from Würzburg, Braunschweig, and the US identifiy Cas12a3 nuclease showing precise activity. Their study is ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...
Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to ...
By a News Reporter-Staff News Editor at CDC& FDA Daily-- Investigators publish new report on RNA Viruses- Coronavirus.
Morning Overview on MSN
Earth’s life-making chemistry may be happening on Mars too
Evidence is mounting that the same basic chemistry that made Earth habitable is unfolding, or once unfolded, on Mars. From ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...
One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...
Morning Overview on MSN
Scientists found a repeating math pattern inside the human body
Scientists mapping the human body at the cellular level keep running into the same surprise: beneath the apparent chaos of ...
RNA probably came before DNA, serving as the storehouse of genetic information and driving chemical reactions; a ...
The companies didn’t provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide ...
The collaboration will support development of Ascidian's RNA exon editor therapy, ACDN-01, for treating the rare genetic eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results